Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 44 drugs
| No. | DrugBank | 薬物名（臨床試験情報から抽出） | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ampreloxetine | 1件: Ampreloxetine Ampreloxetine | 1件: Ampreloxetine
Ampreloxetine
💬1. Ampreloxetine
| 2件: SLC6A2 SLC6A2,SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 17 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Angiotensin II | 2件: Angiotensin Angiotensin; Angiotensin II | 2件: Angiotensin II
Angiotensin II
,Angiotensin II 💬 2. Angiotensin II
| 2件: AGTR1 AGTR1,AGTR2 💬 | 16件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, A ... | 7件: 17 17, 19, 46, 66, 86, 222, 224 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Atomoxetine | 2件: Atomoxetine Atomoxetine; Strattera | 1件: Atomoxetine
Atomoxetine
💬3. Atomoxetine
| 1件: SLC6A2 SLC6A2 💬3. Atomoxetine
| 1件: Synaptic vesicle cycle Synaptic vesicle cycle 💬 | 4件: 6 6, 8, 13, 17 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Botulinum toxin type A | 8件: Botox Botox; Botulinum toxin A; BOTULINUM TOXIN TYPE A; BTX-A; Dysport; IncobotulinumtoxinA; OnabotulinumtoxinA; Xeomin 8件: Botox; Botulinum toxin A; BOTULINUM TOXIN TYPE A; BTX-A; Dysport; IncobotulinumtoxinA; Onabotuli ... | 1件: Botulinum toxin type A
Botulinum toxin type A
💬4. Botulinum toxin type A
| 1件: SNAP25 SNAP25 💬4. Botulinum toxin type A
| 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 14件: 2 2, 5, 6, 7, 13, 15, 17, 36, 47, 51, 70, 113, 149, 226 💬4. Botulinum toxin type A
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | BQ-123 | 0件: | - | - | - | 1件: 17 17 💬5. BQ-123
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Captopril | 1件: Captopril Captopril | 1件: Captopril
Captopril
💬6. Captopril
| 1件: ACE ACE 💬6. Captopril
| 6件: Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyop ... | 8件: 6 6, 17, 46, 86, 96, 97, 107, 271 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Carbidopa | 8件: Carbidopa Carbidopa; Carbidopa-Levodopa; DUODOPA; Lodosyn; PARCOPA; SINEMET; SINEMET CR; Stalevo | 1件: Carbidopa
Carbidopa
💬7. Carbidopa
| 1件: DDC DDC 💬7. Carbidopa
| 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, ... | 7件: 6 6, 13, 17, 90, 140, 164, 201 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Carbonate ion | 1件: Carbonate Carbonate | - | - | - | 12件: 2 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬8. Carbonate ion
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Domperidone | 1件: Domperidone Domperidone | 2件: Domperidone
Domperidone
,Domperidone maleate 💬 9. Domperidone
| 1件: DRD2 DRD2 💬9. Domperidone
| 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 8件: Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor i ... | 5件: 6 6, 13, 17, 51, 230 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Droxidopa | 4件: DOPS DOPS; Droxidopa; L-DOPS; Northera | 1件: Droxidopa
Droxidopa
💬10. Droxidopa
| 9件: ADRA1A ADRA1A,ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chem ... | 5件: 5 5, 6, 17, 169, 170 💬
|